DK1137400T3 - Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode - Google Patents
Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiodeInfo
- Publication number
- DK1137400T3 DK1137400T3 DK99963398T DK99963398T DK1137400T3 DK 1137400 T3 DK1137400 T3 DK 1137400T3 DK 99963398 T DK99963398 T DK 99963398T DK 99963398 T DK99963398 T DK 99963398T DK 1137400 T3 DK1137400 T3 DK 1137400T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptide
- preparation
- compositions containing
- extended release
- subcutaneous implants
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002655A IT1304152B1 (it) | 1998-12-10 | 1998-12-10 | Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato |
PCT/EP1999/009536 WO2000033809A1 (fr) | 1998-12-10 | 1999-12-06 | Compositions contenant un peptide et un acide polylactique-glycolique conçues pour la preparation d'implants sous-cutanes avec duree de liberation prolongee |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1137400T3 true DK1137400T3 (da) | 2004-03-22 |
Family
ID=11381206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99963398T DK1137400T3 (da) | 1998-12-10 | 1999-12-06 | Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode |
Country Status (16)
Country | Link |
---|---|
US (1) | US6620422B1 (fr) |
EP (1) | EP1137400B1 (fr) |
JP (1) | JP4607329B2 (fr) |
KR (1) | KR100676844B1 (fr) |
CN (1) | CN1149975C (fr) |
AT (1) | ATE253893T1 (fr) |
AU (1) | AU757898C (fr) |
BR (1) | BR9916053B1 (fr) |
CA (1) | CA2354034C (fr) |
DE (1) | DE69912836T2 (fr) |
DK (1) | DK1137400T3 (fr) |
ES (1) | ES2211211T3 (fr) |
IT (1) | IT1304152B1 (fr) |
PT (1) | PT1137400E (fr) |
TW (1) | TW561053B (fr) |
WO (1) | WO2000033809A1 (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004535431A (ja) | 2001-06-22 | 2004-11-25 | サザン バイオシステムズ, インコーポレイテッド | ゼロ次長期放出同軸インプラント |
ES2385030T3 (es) | 2001-06-29 | 2012-07-17 | Medgraft Microtech, Inc. | Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso |
KR100885070B1 (ko) * | 2002-05-08 | 2009-02-25 | 재단법인서울대학교산학협력재단 | Plga에 특이적으로 부착하는 올리고 펩타이드 |
DK1532985T3 (en) | 2002-06-25 | 2016-12-05 | Takeda Pharmaceuticals Co | PROCEDURE FOR PREPARING A COMPOSITION WITH LONG-TERM RELEASE |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
NZ541595A (en) | 2003-01-28 | 2008-08-29 | Microbia Inc | Methods and compositions for the treatment of gastrointestinal disorders |
GB0304726D0 (en) * | 2003-03-01 | 2003-04-02 | Ardana Bioscience Ltd | New Process |
ES2291893T3 (es) * | 2003-06-26 | 2008-03-01 | Mediolanum Pharmaceuticals Limited | Implantes subcutaneos con liberacion inicial limitada del principio activo y posterior liberacion prolongada linealmente variable de los mismos. |
ITMI20031302A1 (it) * | 2003-06-26 | 2004-12-27 | Mediolanum Pharmaceuticals Ltd | Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga. |
TWI357815B (en) * | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
JP5105578B2 (ja) | 2003-11-05 | 2012-12-26 | サーコード バイオサイエンス インコーポレイテッド | 細胞接着のモジュレーター |
EP1711159B1 (fr) * | 2003-12-30 | 2013-03-20 | Durect Corporation | Implants solides contenant un block copolymere, pour la liberation controlee de gonadotrophines |
FR2865938B1 (fr) | 2004-02-05 | 2006-06-02 | Sod Conseils Rech Applic | Formulation retard solide comprenant de l'acetate de triptoreline |
PT1781264E (pt) | 2004-08-04 | 2013-10-16 | Evonik Corp | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma |
US20080254086A1 (en) * | 2004-12-23 | 2008-10-16 | Brown James E | Controlled Release Compositions |
SI2444079T1 (sl) | 2005-05-17 | 2017-05-31 | Sarcode Bioscience Inc. | Sestavki in postopki za zdravljenje očesnih motenj |
ITMI20061539A1 (it) * | 2006-08-02 | 2008-02-03 | Mediolanum Pharmaceuticals Ltd | Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo |
ITMI20061538A1 (it) * | 2006-08-02 | 2008-02-03 | Mediolanum Pharmaceuticals Ltd | Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo |
ITMI20061545A1 (it) * | 2006-08-02 | 2008-02-03 | Mediolanum Pharmaceuticals Ltd | Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo |
CN101209238B (zh) * | 2006-12-27 | 2012-05-09 | 辽宁省计划生育科学研究院 | 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备 |
CA3089569C (fr) | 2007-06-04 | 2023-12-05 | Synergy Pharmaceuticals Inc. | Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US8067028B2 (en) * | 2007-08-13 | 2011-11-29 | Confluent Surgical Inc. | Drug delivery device |
CA2958665C (fr) | 2007-10-19 | 2021-03-02 | Sarcode Bioscience Inc. | Compositions et procedes pour le traitement de la retinopathie diabetique |
JP5502751B2 (ja) | 2007-12-20 | 2014-05-28 | エボニック コーポレイション | 低残留溶媒濃度を有する微粒子を調製するためのプロセス |
US20090258069A1 (en) * | 2008-04-15 | 2009-10-15 | John Burnier | Delivery of LFA-1 antagonists to the gastrointestinal system |
WO2009139817A2 (fr) | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Produit pharmaceutique cristallin et ses procédés de préparation et d'utilisation |
JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
EP2321341B1 (fr) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres |
EP2246063A1 (fr) * | 2009-04-29 | 2010-11-03 | Ipsen Pharma S.A.S. | Formulations à libération prolongée contenant des analogues de GnRH |
US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
US9364518B2 (en) | 2010-06-24 | 2016-06-14 | Torrent Pharmaceuticals Limited | Pharmaceutical composition containing goserelin for in-situ implant |
JP6092849B2 (ja) | 2011-05-04 | 2017-03-08 | バランス セラピューティックス, インコーポレイテッドBalance Therapeutics, Inc. | ペンチレンテトラゾール誘導体 |
DE102011114864A1 (de) | 2011-10-05 | 2013-04-11 | Acino Ag | Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat |
EP2877465A4 (fr) | 2012-07-25 | 2016-05-11 | Sarcode Bioscience Inc | Inhibiteur de lfa-1 et polymorphe de celui-ci |
EP2970384A1 (fr) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonistes de la guanylate cyclase et leurs utilisations |
US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
CN103446041B (zh) * | 2013-08-27 | 2015-06-10 | 青岛东辉医药科技发展有限公司 | 一种亮丙瑞林缓控释药棒及其制备方法 |
EP3054969B1 (fr) | 2013-10-10 | 2021-03-10 | Bausch Health Ireland Limited | Agonistes de guanylate cyclase utiles pour le traitement de troubles induits par les opioïdes |
CN105287390A (zh) * | 2015-11-20 | 2016-02-03 | 北京博恩特药业有限公司 | 一种长效醋酸亮丙瑞林微球及其制备方法 |
CN105267153B (zh) * | 2015-11-27 | 2018-05-11 | 上海苏豪逸明制药有限公司 | 一种曲普瑞林缓释微粒及其制备方法 |
CN108884130B (zh) | 2016-01-11 | 2022-09-13 | 博士医疗爱尔兰有限公司 | 用于治疗溃疡性结肠炎的制剂和方法 |
CN105878174B (zh) * | 2016-04-26 | 2021-06-29 | 广州帝奇医药技术有限公司 | 一种固体分散体及其制备方法与应用 |
CN107281493A (zh) * | 2017-06-20 | 2017-10-24 | 苏州乔纳森新材料科技有限公司 | 一种聚乳酸‑聚乙醇酸共聚复合材料及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
CH679207A5 (fr) * | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
JPH07503700A (ja) * | 1991-01-03 | 1995-04-20 | アルカーメス コントロールド セラピューティックス, インコーポレイテッド | カチオン生体ポリマーによるタンパク質の安定化 |
WO1992011843A1 (fr) * | 1991-01-09 | 1992-07-23 | Alza Corporation | Dispositifs bioerodables et compositions pour liberer par diffusion des agents actifs |
CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
US5945128A (en) * | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
EP0948321B1 (fr) * | 1996-12-12 | 2003-10-22 | Dds Drug Delivery Service Gesellschaft Zur Förderung Der Forschung In Pharmazeutischer Technologie Und Biopharmazie Mbh | Preparation sous forme d'un compose materiau matriciel-matiere auxiliaire renfermant eventuellement une matiere active |
-
1998
- 1998-12-10 IT IT1998MI002655A patent/IT1304152B1/it active
-
1999
- 1999-12-06 KR KR1020017006407A patent/KR100676844B1/ko not_active IP Right Cessation
- 1999-12-06 US US09/857,404 patent/US6620422B1/en not_active Expired - Fee Related
- 1999-12-06 AT AT99963398T patent/ATE253893T1/de active
- 1999-12-06 CA CA002354034A patent/CA2354034C/fr not_active Expired - Fee Related
- 1999-12-06 PT PT99963398T patent/PT1137400E/pt unknown
- 1999-12-06 WO PCT/EP1999/009536 patent/WO2000033809A1/fr active IP Right Grant
- 1999-12-06 BR BRPI9916053-6A patent/BR9916053B1/pt not_active IP Right Cessation
- 1999-12-06 AU AU19711/00A patent/AU757898C/en not_active Ceased
- 1999-12-06 ES ES99963398T patent/ES2211211T3/es not_active Expired - Lifetime
- 1999-12-06 DK DK99963398T patent/DK1137400T3/da active
- 1999-12-06 DE DE69912836T patent/DE69912836T2/de not_active Expired - Lifetime
- 1999-12-06 CN CNB998142417A patent/CN1149975C/zh not_active Expired - Fee Related
- 1999-12-06 EP EP99963398A patent/EP1137400B1/fr not_active Expired - Lifetime
- 1999-12-06 JP JP2000586303A patent/JP4607329B2/ja not_active Expired - Fee Related
-
2000
- 2000-03-08 TW TW088121636A patent/TW561053B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR9916053B1 (pt) | 2011-04-19 |
US6620422B1 (en) | 2003-09-16 |
DE69912836T2 (de) | 2004-11-11 |
DE69912836D1 (de) | 2003-12-18 |
IT1304152B1 (it) | 2001-03-08 |
CN1329485A (zh) | 2002-01-02 |
EP1137400A1 (fr) | 2001-10-04 |
BR9916053A (pt) | 2001-09-04 |
JP2002531486A (ja) | 2002-09-24 |
AU757898B2 (en) | 2003-03-13 |
ITMI982655A1 (it) | 2000-06-10 |
KR20010082310A (ko) | 2001-08-29 |
AU1971100A (en) | 2000-06-26 |
PT1137400E (pt) | 2004-03-31 |
TW561053B (en) | 2003-11-11 |
CA2354034C (fr) | 2009-01-27 |
AU757898C (en) | 2003-12-18 |
CN1149975C (zh) | 2004-05-19 |
WO2000033809A1 (fr) | 2000-06-15 |
CA2354034A1 (fr) | 2000-06-15 |
KR100676844B1 (ko) | 2007-01-31 |
JP4607329B2 (ja) | 2011-01-05 |
ES2211211T3 (es) | 2004-07-01 |
ATE253893T1 (de) | 2003-11-15 |
EP1137400B1 (fr) | 2003-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1137400T3 (da) | Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode | |
MY118835A (en) | Sustained release compositions and the process for their preparation | |
ATE249422T1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
ATE393831T1 (de) | Zusammensetzung zur in vivo erzeugung von therapeutischen produkten | |
FI953378A (fi) | Sytokiiniä pidättävät aineet | |
MX9705710A (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento. | |
TR200002299T2 (tr) | Epotilon kompozisyonları. | |
ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
DE69931930D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen | |
UA72915C2 (uk) | Поживна ентеральна композиція, призначена для підтримки зростання та дозрівання недорозвинених шлунково-кишкових трактів у молодих ссавців та її застосування | |
DE69422169D1 (de) | Modifizierte proteine und peptide enthaltende pharmazeutische mittel | |
ATE252375T1 (de) | Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
ATE281155T1 (de) | Medikamentöse verabreichung von proteinen aus polymergemischen | |
SG142165A1 (en) | Biologically active peptides | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
HK1047228A1 (en) | Endoparasiticidal agents | |
ATE208627T1 (de) | Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen | |
DE60010230D1 (de) | Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung | |
DE602004019141D1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide | |
MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. | |
NZ335409A (en) | Use of a burst free controlled release poly(lactide/glycolide) microcapsule pharmaceutical formulation | |
TW200611913A (en) | Biologically active peptides (Ⅲ) |